Lexicon Pharmaceuticals, Inc. NDCs and Package Codes
This page lists NDC package records associated with labeler code 70183 (Lexicon Pharmaceuticals, Inc.) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.
Key stats
6
Package NDCs
7
Products
7
Active listings
0
Discontinued
2
Ingredients
0
Therapeutic classes
1
Dosage forms
2
With NADAC pricing
Portfolio
Top ingredients
By dosage form
Browse records — 7 products
| Drug / product | Billing NDC | NADAC / unit | Status | |
|---|---|---|---|---|
| INPEFA sotagliflozin 200 mg/1 TABLET | 70183-0221-07 | — | On market | View → |
| INPEFA sotagliflozin 200 mg/1 TABLET | 70183-0220-07 | — | Discontinued | View → |
| INPEFA sotagliflozin 400 mg/1 TABLET | 70183-0241-30 | — | On market | View → |
| INPEFA sotagliflozin 400 mg/1 TABLET | 70183-0241-30 | — | On market | View → |
| INPEFA sotagliflozin 200 mg/1 TABLET | 70183-0221-07 | — | On market | View → |
| Xermelo telotristat ethyl 250 mg/1 TABLET | 70183-0125-85 | — | Discontinued | View → |
| Xermelo telotristat ethyl 250 mg/1 TABLET | 70183-0125-85 | — | Discontinued | View → |
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.